Apexbio Paclitaxel

Paclitaxel (Taxol)

A4393-100 100 mg
EUR 142
Description: Paclitaxel is a novel antineoplastic agent, which was discovered in a screen of extracts of thousands of plants and natural products for antineoplastic activity by a National Cancer Institute program

Apexbio Reagents Laboratories manufactures the apexbio paclitaxel reagents distributed by Genprice. The Apexbio Paclitaxel reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Apexbio Reagents. Other Apexbio products are available in stock. Specificity: Apexbio Category: Paclitaxel

Human Samples information

Phos-tag Biotin BTL-104

F4001-5 5 mg
EUR 456

Phos-tag Biotin BTL-104

F4001-50 50 mg
EUR 1500

Phos-tag Acrylamide

F4002-10 10 mg
EUR 630

Phos-tag Acrylamide

F4002-5 5 mg
EUR 456

Phos-tag Acrylamide

F4002-50 50 mg
EUR 1500

Phos-tag Biotin BTL-105

F4004-10 10 mg
EUR 630

Phos-tag Biotin BTL-105

F4004-5 5 mg
EUR 456

Phos-tag Biotin BTL-105

F4004-50 50 mg
EUR 1500

4-Quinolone-3-Carboxamide Furan CB2 Agonist

C3511-10 10 mg
EUR 440
Description: Ki: 8.5 nM4-Quinolone-3-Carboxamide Furan CB2 Agonist is a high-affinity ligand of CB2.The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors (primarily CB1 and CB2), and the enzymes that synthesize and degrade endocannabinoids.

4-Quinolone-3-Carboxamide Furan CB2 Agonist

C3511-25 25 mg
EUR 902
Description: Ki: 8.5 nM4-Quinolone-3-Carboxamide Furan CB2 Agonist is a high-affinity ligand of CB2.The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors (primarily CB1 and CB2), and the enzymes that synthesize and degrade endocannabinoids.

4-Quinolone-3-Carboxamide Furan CB2 Agonist

C3511-5 5 mg
EUR 270
Description: Ki: 8.5 nM4-Quinolone-3-Carboxamide Furan CB2 Agonist is a high-affinity ligand of CB2.The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors (primarily CB1 and CB2), and the enzymes that synthesize and degrade endocannabinoids.

KT182

C3516-10 10 mg
EUR 241
Description: IC50: < 5 nMKT182 is an ABHD6 inhibitor.

KT182

C3516-5 5 mg
EUR 154
Description: IC50: < 5 nMKT182 is an ABHD6 inhibitor.

KT203

C3518-10 10 mg
EUR 241
Description: IC50: < 5 nMKT203 is an ABHD6 inhibitor. ABHD6, a unique and highly conserved enzyme in mammals, is prominently expressed in brain, liver, kidney, and brown adipose tissue based on global gene expression analysis and activitybased protein profiling (ABPP).

KT203

C3518-5 5 mg
EUR 154
Description: IC50: < 5 nMKT203 is an ABHD6 inhibitor. ABHD6, a unique and highly conserved enzyme in mammals, is prominently expressed in brain, liver, kidney, and brown adipose tissue based on global gene expression analysis and activitybased protein profiling (ABPP).

Arylquin 1

C3520-10 10 mg
EUR 258
Description: Arylquin 1 is a potent secretagogue of the tumor suppressor protein prostate apoptosis response-4 (Par-4).Par-4 is ubiquitously expressed in normal cells and tissues, but it is inactivated, downregulated or mutated in several types of cancers.

Arylquin 1

C3520-5 5 mg
EUR 171
Description: Arylquin 1 is a potent secretagogue of the tumor suppressor protein prostate apoptosis response-4 (Par-4).Par-4 is ubiquitously expressed in normal cells and tissues, but it is inactivated, downregulated or mutated in several types of cancers.